Clinical Trial Update: Randomized Study In Severe Aplastic Anemia Patients Receiving Atg, Cyclosporin A, With Or Without G-CSF (SAA-G-CSF) [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating ATG with or without G-CSF in severe aplastic anemia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Antithymocyte Globulin (anti-thymocyte globulin)
• Cyclosporin A (cyclosporine)
• G-CSF (granulocyte colony-stimulating factor)

Snippet

Sponsor: European Society for Blood and Marrow Transplantation | Conditions: Aplastic Anaemia | Phase 3 | Status: TERMINATED